Based on the existing varieties, brands, channels and marketing advantages, Jointown conducts targeted development of self-operated industrial and OEM products by virtue of big data accumulated by the Company's "hundred-billion-level" supply chain service platform, and then distributes pharmaceuticals to terminal or C-end consumers through its full-channel sales network.

Beijing Jingfeng Pharmaceutical Group Co., Ltd. is a manufacturer specializing in production, sales, research and development of drugs, and incubators. Its main products include a series of medications for diabetes, topical applications, respiratory infections, cardiovascular conditions, and neurological systems. Based on the strategic positioning of "full business coverage, industry chain synergy and integration of production, marketing and research", Jingfeng Pharmaceutical continues to strengthen quality management and brand promotion. It is consistently advancing the consistency evaluation of generic drugs, aiming to develop metformin tablets as a flagship product and nurturing high-quality products that integrate raw materials with formulations. Jingfeng Pharmaceutical has over 300 approval numbers and more than 150 varieties approved and to be approved for market sale. Jingfeng Pharmaceutical will become a modern industrial enterprise with the most comprehensive dosage forms, the most varieties, the best quality and the largest capacity in China.

As a platform company for the traditional Chinese medicine industry, JiuXin TCM focuses on the comprehensive health industry of traditional Chinese medicine, and intensifies efforts in the whole industrial chain in the fields of traditional Chinese medicinal materials resource, research and development, production, marketing and e-commerce, with geo-authentic herb and quality assurance as the core competitiveness.

Jiuxin TCM has established 9 core Daodi Herb production areas nationwide, invested in the construction of 21 specialized Daodi Herb companies, and standardized the cultivation of 250,000 acres of medicinal material bases, managing over 70 Daodi Herbs. Among them, 14 traditional Chinese medicinal material bases, including Angelica sinensis, Milkvetch root, Pilose Asiabell root and Gastrodia elata, have obtained GAP certification. Additionally, 15 medicinal varieties, such as Weeping Forsythia capsule, Solomonseal Rhizome, Lucid Ganoderma and Poria cocos, have been recognized as " Tri-harmlessness and traceability" brand bases. Meanwhile, a quality traceability platform for traditional Chinese medicine has been designed and established in Hubei Province, truly ensuring that the circulation of traditional Chinese medicinal materials is "traceable in origin, verifiable in destination, and accountable in responsibility". Jiuxin TCM has established 13 GMP-certified modern herbal piece enterprises, and is dedicated to establishing an application-based "industry-university-research" integrated TCM technology R&D platform. It boasts a core technology R&D team of over 70 members, undertakes more than 30 national and provincial key projects, participates in the formulation of 50 national and local standards, and has developed a cluster of over 200 patents covering the stages of cultivation, processing, and testing.

In terms of medical device OEM business, Jointown focuses on household medical devices, infection control consumables, rehabilitation consumables, high-value consumables, and IVD. The Company acquires products in form of OEM, ODM, ownership, clinical outcome commercialization, industrial mergers and acquisitions, etc. It has also established R&D mechanisms and its own supply chains, set up a professional marketing team for household medical devices and medical services, and fully exploited its marketing resources to develop new channels to expand the market, thus forming an industrial system integrating industry, university, research, investment, and sales for its own products. In terms of drug OEM business, OEM drugs operated by the Company include product specifications such as tablets, capsules, oral liquids, compound granule products, etc. Through independent R&D and the production of products under its self-owned brands and OEM products, Jointown has developed products with independent intellectual property rights and right of exclusive sales, improving product competitiveness. In addition, Jointown has continued to expand external sales channels, promote product sales, and increase market share to build a foundation for the implementation of new product strategies.